CN Patent

CN111848626B — Trk激酶抑制剂及其用途

Assigned to Jiangsu Carephar Pharmaceutical Co ltd · Expires 2021-11-30 · 4y expired

What this patent protects

本发明公开一种TRK激酶抑制剂及其用途，本发明所述的TRK激酶抑制剂如式(I)所示，还提供了所述化合物的制备方法、包含有这些激酶抑制剂的药物组合物及其在预防与治疗癌症中的用途；本发明公开的式I所示的新化合物，表现出了良好的TRK抑制活性，为临床治疗与TRK活性异常相关的疾病提供了一种新的选择，

USPTO Abstract

本发明公开一种TRK激酶抑制剂及其用途，本发明所述的TRK激酶抑制剂如式(I)所示，还提供了所述化合物的制备方法、包含有这些激酶抑制剂的药物组合物及其在预防与治疗癌症中的用途；本发明公开的式I所示的新化合物，表现出了良好的TRK抑制活性，为临床治疗与TRK活性异常相关的疾病提供了一种新的选择，

Drugs covered by this patent

Patent Metadata

Patent number
CN111848626B
Jurisdiction
CN
Classification
—
Expires
2021-11-30
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Carephar Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.